Management of Psoriasis with Kushtanashana rasa and Kutaja suryapaki taila -A clinical study

Not yet recruiting

• Conditions: Psoriasis, unspecified,

• Registration Number: CTRI/2020/03/024089
• Lead Sponsor: Dr Supreetha M

Brief Summary

Psoriasis is one of the most common skin disease which has no permanent cure available.The current treatment modalities available are palliative lotions,ointments and PUVA (Psoralin Ultra Violet A) and Biologic injections which are very expensive and is recommended for long period of time. Psoriasis is having high recurrance rate and often the patient with Psoriasis experience diminished quality of life. Hence there is a need to contribute with safe and effective remedy for its treatment.

Hypothesis:

Null Hypothesis-H0 :The efficacy of Kushtanashana Rasa in the mangement of Eka kushta w.s.r to Psoriasis is insignificant.

Research Hypothesis- H1 :1. The efficacy of Kushtanashana Rasa in the management of Eka kushta w.s.r to Psoriasis is significant.

2. The efficacy of Kushtanashana Rasa in the management of Eka kushta w.s.r to Psoriasis is significant in comparison to control groups.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2020-03-19
• Study Start: 2020-03-23

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• 1.With classical signs and symptoms of Eka Kushta.
• Presenting with signs and symptoms of Psoriasis.
• The Subjects willing to give informed consent for research.

Exclusion Criteria

• 1.Subjects aged <21 years and > 60 years of age .
• 2.Subjects suffering from complications of Psoriasis like Psoriatic arthritis .
• 3.Subjects suffering from Non–psoriatic conditions of skin, IHD, Immune compromised patients and other uncontrolled systemic diseases.
• 4.Disease which interferes with the course of disease and treatment.
• 5.Pregnant and Lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in PASI Scale score	16th day,32nd day,49th day and 65th day

Secondary Outcome Measures

Name	Time	Method
Reduction in DLQI scale score	16th day,32nd day,49th day and 65th day

Trial Locations

Locations (1)

Sri Sri College of Ayurvedic Science and Research Hospital; 🇮🇳 Bangalore, KARNATAKA, India

Sri Sri College of Ayurvedic Science and Research Hospital

🇮🇳Bangalore, KARNATAKA, India

Dr SupreethaM

Principal investigator

8660550443

supree99@gmail.com